Board of Directors
Young Hee Ko, PhD
Owner, CEO & CSO
Founder, CEO and CSO of KoDiscovery, LLC. Owner, CEO and CSO of PrimoCure Pharma, Inc. Biophysicist, Biochemist, Cellular and Metabolic Research Scientist. In 2000, while at Johns Hopkins, she discovered the anticancer potential of 3-Bromopyruvate, which has led her to receive numerous worldwide patents for her formulation, KoDiscovery Anticancer Technology (KAT), to potentially treat up to 95% of all cancers.
Travis Christofferson
Secretary
MS in Materials Engineering and Science.
Co-founder of Care Oncology USA. Clinical development for StageZero Life Sciences. Founder and President of The Foundation for Metabolic Cancer Therapies. Author of three books on cancer metabolism and the Health Care system.
Pete L. Pedersen, PhD
Director
Biological Chemistry and Oncology at Kimmel Cancer Center at Johns Hopkins University, School of Medicine. For forty years, Dr. Pedersen led primary research elucidating the detailed mechanisms of action of Otto Warburg’s discoveries regarding the unique metabolic properties of cancer cells.